Complete list of publications

(2020). Summarising salient information on historical controls: A structured assessment of validity and comparability across studies. Clinical Trials (accepted for publication).

(2020). Cannabidiol for the treatment of cannabis use disorder: Phase IIa double-blind placebo-controlled randomised adaptive Bayesian dose-finding trial. The Lancet Psychiatry.

(2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health.

Project DOI ConVOI website

(2020). Why counting coronavirus deaths is not an exact science. Why counting coronavirus deaths is not an exact science. The Guardian 19 April 2020.

The Guardian

(2020). Are Missing Data Properly Accounted for in Health Economics and Outcomes Research?. Value and Outcomes Spotlight, March/April 2020.

Project PDF ISPOR SIG

(2020). Practical Considerations for the Efficient Computation of the Expected Value of Sample Information to Prioritize Research in Health Care. Medical Decision Making.

Project ConVOI website

(2020). Calculating the Expected Value of Sample Information in Practice: Considerations from three case studies. Medical Decision Making.

Project DOI ConVOI website

(2020). Bayesian Background. In Lesaffre E, Baio G and Boulanger B (eds), Bayesian Methods for Pharmaceutical Research.

Book website (CRC) Book website

(2019). Computing the Expected Value of Sample Information Efficiently: Expertise and Skills Required for Four Model-Based Methods.

PDF ConVOI website

(2019). Calculating the Expected Value of Sample Information in Practice: Considerations from Three Case Studies.

Project PDF ConVOI website

(2019). Bayesian Statistical Economic Evaluation Methods for Health Technology Assessment. Oxford Encyclopedia of Health Economics.

DOI Go to book website

(2019). Bayesian modelling for binary outcomes in the Regression Discontinuity Design. Journal of the Royal Statistical Society: Series A (Statistics in Society).

PDF Project DOI

(2019). A Bayesian parametric approach to handle missing longitudinal outcome data in trial-based health economic evaluations. Journal of the Royal Statistical Society: Series A (Statistics in Society).

PDF Project DOI

(2018). Modelling Outcomes of Soccer Matches. Machine Learning.

PDF Project DOI

(2018). Statistical Modeling for Health Economic Evaluations. Annual Review of Statistics and its Application.

PDF Video DOI

(2017). Evaluating the benefits of community based aerobic training on the physical health and well-being of people with Charcot-Marie-Tooth disease type 1A: a pilot randomised controlled trial. Journal of the Peripheral Nervous System.

PDF

(2017). Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy. Cost Effectiveness and Resource Allocation.

PDF Project DOI

(2017). The association between psychological stress and miscarriage: A systematic review and meta-analysis. Scientific Reports.

PDF DOI

(2017). Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial. PLoS Medicine.

PDF DOI

(2016). Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods. Value in Health.

PDF

(2016). Normative aerobic excercise value in CMT. Journal of the Peripheral Nervous System.

PDF

(2016). Evaluating the benefits of community based aerobic traning on the physical health and well-being of people with Charcot-Marie-Tooth disease Type 1A. Journal of the Peripheral Nervous System.

PDF

(2016). Evaluating the Benefits of Community Based Aerobic Training on the Physical Health and Well-Being of People with Neuromuscolar Disease. Muscle & Nerve.

PDF

(2016). A Bayesian Nonparametric Model for White Blood Cells in Patients with Lower Urinary Tract Symptoms. Electronic Journal of Statistics.

PDF DOI

(2016). When simple becomes complicated: Why Excel should lose its place at the top table. Global & Regional Health Technology Assessment.

PDF Project DOI

(2016). Treatment of Polycystic Ovary Syndrome in UK Primary Care 2004-2012. Pharmacoepidemiology and Drug Safety.

PDF Project

(2016). The Regression Discontinuity Design in Epidemiology. Pharmacoepidemiology and Drug Safety.

PDF

(2016). Do GPs Adhere to the Guidelines? A Study Based on Statins Prescriptions. Pharmacoepidemiology and Drug Safety.

PDF

(2015). Urinary ATP as an indicator of infection and inflammation of theurinary tract in patients with lower urinary tract symptoms. BMC Urology.

PDF DOI

(2015). Comparison of computer-assisted planning and manual planning for depth electrode implantations in epilepsy. Journal of Neurosurgery.

PDF DOI

(2015). Estimating the Cost-Effectiveness Profile of a Vaccination Programme with a Nine-Valent HPV Vaccine in Italy. Value in Health.

PDF Project DOI

(2015). Evaluating the benefits of community based aerobic training on the physical health and well-being of people with neuromuscular diseases: A pilot study. Neuromuscolar Disorders.

PDF DOI

(2015). Cost-effectiveness analysis of universal human papillomavirus vaccination using a dynamic Bayesian methodology: The BEST II study. Value in Health.

PDF Project DOI

(2015). Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months. Journal of Medical Screening.

PDF DOI

(2015). Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014. Trials.

PDF Project DOI

(2015). Sample size calculation for a stepped wedge trial. Trials.

PDF DOI

(2015). Five questions to consider before conducting a stepped wedge trial. Trials.

PDF Project DOI

(2015). An Educational Review of the Statistical Issues in Analysing UtilityData for Cost-Utility Analysis. PharmacoEconomics.

PDF DOI

(2015). Monetary costs of agitation in older adults with Alzheimer's diseasein the UK: prospective cohort study. BMJ open.

PDF DOI

(2015). Health utilities lost and risk factors associated with HPV-induceddiseases in men and women: The HPV Italian collaborative study group. Clinical Therapeutics.

PDF Project DOI

(2015). Cost-effectiveness and affordability of community mobilisation throughwomen's groups and quality improvement in health facilities (MaiKhandatrial) in Malawi. Cost Effectiveness and Resource Allocation.

PDF DOI

(2015). A predictable outcome. Significance Magazine.

PDF DOI

(2014). Non-pharmacological interventions for agitation in dementia: systematicreview of randomised controlled trials. British Journal of Psychiatry.

PDF DOI

(2014). The effect of herd immunity in different human papillomavirus vaccinationstrategies: an economic evaluation of the BEST II study. Value in Health.

PDF Project

(2014). A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technology Assessment.

PDF DOI

(2014). Telomere length in human blastocysts. Reproductive Biomedicine Online.

PDF DOI

(2014). Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data. British Medical Journal.

PDF Project DOI

(2014). Preformulated implementation intentions to promote colorectal cancerscreening: A cluster-randomized trial. Health Psychology.

PDF DOI

(2013). Spatial and spatio-temporal models with R-INLA. Spatial and Spatio-temporal Epidemiology.

PDF DOI

(2013). Risk factors influencing the viral transmission and the potential development of HPV-induced pathologies. Value in Health.

PDF

(2013). Evaluating the benefits of community based aerobic training on the physical health and well-being of people with neuromuscular diseases: a pilot study. Journal of the Peripheral Nervous System.

PDF

(2013). Loss of health utilities due to HPV-induced diseases in men and women: a multicenter Italian study. Value in Health.

PDF DOI

(2013). Transparency or proper study valuation procedures missed?. Medical Care.

PDF DOI

(2013). Methodological issues for the economic evaluation of health interventions: A concise state of the art. Epidemiology Biostatistics and Public Health.

DOI

(2013). Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy. PLoS One.

PDF DOI

(2012). Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: The BEST study. Medical Care.

Project DOI

(2012). Economic burden of human papilloma virus-related diseases in Italy. PLoS One.

PDF Project DOI

(2012). The prevalence of primary angle closure glaucoma in European derived populations: A systematic review. British Journal of Ophthalmology.

DOI

(2012). Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. British Journal of Cancer.

PDF DOI

(2012). Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study. BMJ Open.

PDF Project DOI

(2011). Probabilistic Sensitivity Analysis in Health Economics. Statistical Methods in Medical Research.

PDF DOI

(2011). Centre Sampling Technique in Foreign Migration Surveys: A Methodological Note. Journal of Official Statistics.

(2011). Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. International Journal of Epidemiology.

DOI

(2011). Bayesian modelling assessing the effectiveness of a vaccination strategy to prevent HPV-related diseases: The BEST study. Value in Health.

PDF

(2011). Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis. Expert Opinion on Pharmacotherapy.

PDF DOI

(2010). Bayesian hierarchical model for the prediction of football results. Journal of Applied Statistics.

Project DOI

(2009). Health economic evaluation of the treatment of osteoporosis in five Italian regions. Value in Health.

PDF

(2009). A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. Studies in Health Technology and Informatics.

PDF DOI

(2008). Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models. Pharmacoepidemiology and Drug Safety.

PDF DOI

(2007). Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities. Value in Health.

PDF DOI

(2007). Handling manipulated evidence. Forensic Science International.

PDF DOI

(2007). An Introduction to Bayesian Modelling for Social Sciences. Best Practice in Quantitative Methods.

PDF

(2006). Object Oriented Influence Diagram for Cost Effectiveness Analysis of Influenza Vaccination in Italian Elderly Population. Expert Review of Pharmacoeconomics & Outcomes Research.

DOI

(2005). Economic evaluation of HIV treatments: the I.CO.N.A. cohort study. Health Policy.

PDF DOI

(2005). Medical Devices Competitiveness and Impact on Public Health Expenditure.

PDF

(2004). Economic evaluation of HIV treatments: The I.CO.N.A cohort study. Value in Health.

PDF DOI

(2003). Pharmacoutilization and costs of osteoarthritis: changes inducedby the introduction of a cyclooxygenase-2 inhibitor into clinicalpractice. Rheumatology (Oxford).

PDF DOI

(2003). Bayesian cost-effectiveness analysis based on the persistence with antihypertensive treatment. Expert Review of Pharmacoeconomics & Outcomes Research.

PDF DOI

(2002). Persistence with anti hypertensive drug treatment: An evaluation based on a Bayesian cost-effectiveness approach. Value in Health.

PDF

(2002). Cost allocation in antihypertensive drug therapies. Expert Review of Pharmacoeconomics & Outcomes Research.

DOI

(2002). [Evaluation model of the effect of Rofecoxib on the co-prescriptionof gastroprotective agents observed during the treatment of osteoarthritis].. Reumatismo.

PDF

(2002). A retrospective, population-based analysis of persistence with antihypertensivedrug therapy in primary care practice in Italy.. Clinical Therapeutics.

PDF DOI

(2002). Long-term persistence with antihypertensive drugs in new patients.. Journal of Human Hypertension.

PDF DOI

(2002). Modello valutativo dell'effetto sulla co-prescrizione di gastroprotettoriosservato durante il trattamento dell'artrosi con rofecoxib. Reumatismo.

(2001). Una prima valutazione economica dell'impiego di rofecoxib versusFANS convenzionali nell'artrosi. PharmacoEconomics - Italian Research Articles.